SAN FRANCISCO, Calif. — MPM Capital announced today the closing of the MPM BioEquities Fund to new investors. The Fund raised over $400 million since its inception March 23, 2001 and now stands at over $450 million in assets.
The MPM BioEquities Fund invests primarily in publicly traded biotechnology stocks. The fund is supported by a team of 5 analysts, in conjunction with the 18 biotech and life sciences professionals supporting MPM Capital’s BioVentures Funds.
LOS ANGELES — US SEARCH.com Inc. (Nasdaq:SRCH) today reported that it has completed a $3.5 million private financing agreement with Pequot Ventures, the venture capital arm of Pequot Capital Management Inc. The financing will enable US SEARCH to continue its announced corporatedevelopment and acquisition strategies and build on the company’s leadership in the large and growing trust and risk mitigation markets.
Under the terms of the new financing agreement, the Company issued Pequot Ventures $3,500,000 in principal amount of its 8% Convertible Promissory Notes plus warrants to purchase approximately 1.1 million additional shares of common stock. The Notes may be converted into discounted common stock or other securities pursuant to the terms of the agreement.
MURRAY HILL, NJ — Lucent Technologies (NYSE:LU) and Coller Capital of London today announced that they have created a new venture capital partnership named New Venture Partners II LP (NVP II). NVP II will own and manage the former Lucent New Ventures Group (NVG) portfolio of businesses, which has its roots in Lucent